Charles J. Homcy is Chairman at BridgeBio Pharma, Inc. (BBIO). They have made 14 open-market trades across 4 companies since 2006, most recently 2026-06-22.
CIK 0001192591
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BBIO | SELL · 10b5-1 | 2025-08-08 | 2025-08-12 | $46.23 | $25.4M | -1.0% | +6.0% | +26.6% |
| BBIO | SELL | 2020-10-16 | 2020-10-19 | $41.00 | $420K | -2.0% | +9.1% | +74.6% |
| BBIO | SELL | 2020-09-30 | 2020-10-01 | $38.00 | $380K | +1.1% | -1.8% | +78.3% |
| BBIO | SELL | 2020-09-25 | 2020-09-29 | $36.90 | $6.7M | +4.4% | +3.3% | +84.4% |
| BBIO | SELL | 2020-02-10 | 2020-02-12 | $36.00 | $720K | -7.1% | -32.9% | -4.5% |
| BBIO | SELL | 2020-01-14 | 2020-01-16 | $35.00 | $350K | -3.1% | -3.6% | -24.9% |
| PTLA | SELL | 2018-12-17 | 2018-12-19 | $18.60 | $2.4M | +11.3% | +57.4% | +98.2% |
| GBT | SELL | 2017-10-26 | 2017-10-27 | $33.97 | $2.4M | +12.0% | +13.8% | +73.9% |
| PTLA | SELL | 2017-06-23 | 2017-06-27 | $53.06 | $12.8M | +7.8% | +14.9% | -2.5% |
| GBT | SELL | 2017-06-01 | 2017-06-22 | $27.09 | $5.4M | -1.2% | +2.4% | -3.2% |
| PTLA | SELL | 2017-03-15 | 2017-03-16 | $40.06 | $2.0M | -1.8% | -4.4% | -7.6% |
| PTLA | SELL | 2017-03-01 | 2017-03-03 | $37.50 | $938K | +6.8% | +1.8% | -4.8% |
| PTLA | SELL · 10b5-1 | 2015-09-18 | 2015-09-18 | $56.25 | $2.3M | -25.1% | -4.2% | -4.2% |
| PTLA | SELL · 10b5-1 | 2015-07-13 | 2015-07-14 | $48.00 | $2.4M | -25.1% | -4.2% | -4.2% |
| PTLA | SELL · 10b5-1 | 2015-06-29 | 2015-06-29 | $43.78 | $4.4M | -25.1% | -4.2% | -4.2% |
| PTLA | SELL · 10b5-1 | 2015-02-23 | 2015-02-23 | $40.00 | $800K | -25.1% | -4.2% | -4.2% |
| PTLA | SELL · 10b5-1 | 2015-02-17 | 2015-02-17 | $36.00 | $720K | -25.1% | -4.2% | -4.2% |
| PTLA | SELL · 10b5-1 | 2015-02-13 | 2015-02-13 | $34.05 | $681K | -25.1% | -4.2% | -4.2% |
| PTLA | SELL · 10b5-1 | 2015-01-28 | 2015-01-28 | $30.00 | $591K | -25.1% | -4.2% | -4.2% |
| PTLA | SELL · 10b5-1 | 2015-01-27 | 2015-01-27 | $30.00 | $9K | -25.1% | -4.2% | -4.2% |
| PTLA | SELL | 2013-10-22 | 2013-10-23 | $23.75 | $2.3M | -25.1% | -4.2% | -4.2% |
| MLNM | SELL · 10b5-1 | 2007-12-11 | 2007-12-13 | $15.81 | $937K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-09-17 | 2007-09-19 | $10.42 | $938K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-09-04 | 2007-09-06 | $10.20 | $306K | N/A | N/A | N/A |
| MLNM | SELL | 2007-02-16 | 2007-02-20 | $11.24 | $312K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.